Trials to begin on new Australian COVID-19 vaccine

SA researchers are behind the new DNA vaccine that targets the Omicron variant
Australian Associated Press
Dr Makutiro Masavuli from the Basil Hetzel Institute researching the vaccine. Credit: University of Adelaide

A new COVID-19 vaccine developed in SA and administered with a needle-free device is to begin use in human trials.

The DNA vaccine targets the Omicron variant, whereas the Pfizer, AstraZeneca, Moderna and Novavax vaccines target the original strain of the virus.